Replies to post #34263 on Cytogenix (fka CYGX)

[bigworld]

David02835: Yeah, I'm back from Austin, Texas...my next and future home. It was great. Nothing much to say about CYGX. It hasn't done much since I left 10 days ago, and there is no news. The stock has held up well considering the relatively light volume and the lack of news. I suppose a nice PR might send us off to the races again. It would be nice to have one good PR before the shareholders' meeting. I can't attend this one, but if I'm still holding the stock next year I will make the drive from Austin to Houston for the next SH meeting.

[gdepc]

david

I am talking about major pharma players in the bird flu arena not cygx only

Any company that has made progress with the bird flu would be a candidate

I am looking more towards cygx would supply there syn dna to the major pharmas


Gdepc

[Paulness]

david02835 do you remember this PR with GE and this is a big company willing to help us with Grants and Fast Trak.

CytoGenix and GE Healthcare Ink BioDefense Support Agreement
Houston, TX, (December 27, 2005) Cytogenix, Inc. (CYGX.OB)

Houston, (December 27, 2005) CytoGenix, Inc. (CYGX.OB) announced today the signing of a contract with the Fast Trak BioDefense group of GE Healthcare a unit of General Electric Company (NYSE:GE).

GE Healthcare's Fast Trak BioDefense group has a diverse staff of highly qualified technical and regulatory experts who will collaborate with CytoGenix in seeking, obtaining and executing bio-defense related federal contracts.

Frank Vazquez, CytoGenix, Inc. Executive Vice President and COO commented, "Our association with GE Healthcare, a $14 Billion entity of GE as partners in competing for federal research projects sends a very positive message to grant reviewers and granting agencies at the Department of Homeland Security, the Department of Defense and the Department of Health and Human Services. We are very excited about this relationship and expect to see very positive results soon."

Dr. Sandy Weinberg, Senior Director, Fast Trak BioDefense GE Healthcare commented, "Cytogenix' innovative DNA vaccine and antimicrobial technology can be applied to many critical needs in bio-defense. The company has an excellent team of scientists and, we expect that with our assistance we can attain substantial results."